Wall Street giant Morgan Stanley promoted 173 of its employees to managing director roles this year, marking a 12% increase ...

Morgan Stanley’s Asia wealth chief is looking to boost the number of staff dealing with its richest customers as the US ...

Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an "overweight" rating, shifting from "equal-weight," and have also increased their price target to $20 from $10. The ...

Among 26 home price forecast models tracked by ResiClub, Morgan Stanley is the most bearish on the 2025 housing market.

At Morgan Stanley, 2024 marked Ted Pick’s first full year at the helm of the firm and the restrained size of its new MDs ...

At Morgan Stanley, the new class is the first set of MD promotions under chief executive Ted Pick, who took the helm of the ...

Jim Caron of Morgan Stanley Investment Management explains what's behind the steepening yield curve and what it's telling us ...

Investing.com -- Hermes shares are edging up, rebounding from intraday lows after Morgan Stanley (NYSE: MS) highlighted the ...

Morgan Stanley initiated coverage of Palantir Technologies Inc. (NYSE:PLTR) with an underweight rating and $60 price target ...

Sana Biotechnology (NASDAQ:SANA) climbed over 200% on Wednesday following a sharp rally in the post-market yesterday in ...

Mike Wilson says 2025 may be "a year of two halves" as stocks face high yields and a strong dollar before Trump's pro-market ...

Morgan Stanley noted this in a report on the 8th. The firm maintained its investment opinion of 'overweight' on Samsung ...